EICHOR
● Enrolling By Invitation
Plasma Exosome RNA to Diagnose Prostate Cancer
Condition: Prostate Cancer · Sponsor: Xijing Hospital
About this study
The aim of the present study is to investigate a RNA combination to diagnose prostate cancer.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (9)
| The First Hospital of Lanzhou University | Lanzhou, Gansu, China | — |
| General Hospital of Ningxia Medical University | Yinchuan, Ningxia, China | — |
| Qinghai University Affiliated Hospital | Xining, Qinghai, China | — |
| Weinan Central Hospital | Weinan, Shaanxi, China | — |
| Shaanxi Provincial People's Hospital | Xi'an, Shaanxi, China | — |
| Xijing 986 Hospital | Xi'an, Shaanxi, China | — |
| Xijing Hospital | Xi'an, Shaanxi, China | — |
| The Second Affiliated Hospital of Shaanxi University of Chinese Medicine | Xianyang, Shaanxi, China | — |
| Affiliated Hospital of Yan'an University, | Yan’an, Shaanxi, China | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06604130